Human transferrin has been biolabelled with gold nanoclusters (Au NCs) using a simple, fast and non-toxic method. These nanocrystals (<2 nm) are stabilized in the protein via sulfur groups and have a high fluorescence emission in the near infrared region (QY=4.3%; λem=695 nm). Structural investigation and photophysical measurements show a high population of clusters formed of 22-33 gold atoms covalently bound to the transferrin. In solutions with pH ranging from 5 to 10 and in buffer solutions (PBS, HEPES), those biolabelled proteins exhibit a good stability. No significant quenching effect of the fluorescent transferrin has been detected after iron loading of iron-free transferrin (apoTf) and in the presence of a specific polyclonal antibody. Additionally, antibody-induced agglomeration demonstrates no alteration in the protein activity and the receptor target ability. MTT and Vialight® Plus tests show no cytotoxicity of these labelled proteins in cells (1 µg ml(-1)-1 mg ml(-1)). Cell line experiments (A549) indicate also an uptake of the iron loaded fluorescent proteins inside cells. These remarkable data highlight the potential of a new type of non-toxic fluorescent transferrin for imaging and targeting.
A panel of silver nanoclusters (Ag NCs) protected by glutathione has been produced by collecting them on a plastic surface during an interfacial etching process. Blue-green, yellow and red emitting Ag NCs with size smaller than 2 nm exhibited distinct fluorescence properties (both emission and lifetime). In particular, the yellow emitting Ag NCs were found to reach a very high quantum yield of over 60% with a monoexponential fluorescence lifetime. These labels show no bleaching and high photostability over time and a high stability for a wide range of pH values. Cytotoxicity tests demonstrated the viability in the presence of of these luminescent probes even at high concentration (1 mg/mL). Cell studies confirmed the uptake of Ag NCs in epithelial lung cancer cells by an endocytotic process. These results show the high potential of fluorescent noble metal nanoclusters for biolabeling and imaging as alternatives to the standard fluorescent probes such as quantum dots or organic dyes.
18 February 2020 in Journal of Materials Chemistry B
In parallel with the rapidly growing and widespread use of nanomedicine in the clinic, we are also witnessing the development of so-called theranostic agents that combine diagnostic and therapeutic properties.